Evidence map›Paper›PMID 42171405›Full record

ArticleAngewandte Chemie (International ed. in English)2026

Metal-Free Active Template: A Straightforward Route to 4-Aminopyridinium-Based Rotaxane Molecular Shuttles.

Ivaylo Stoyanov, Arie van der Lee, Frédéric Coutrot

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ivaylo StoyanovSupramolecular Machines and Architectures Team, Institut des Biomolécules Max Mousseron, CNRS, Université de Montpellier, ENSCM, Montpellier, France.ORCID https://orcid.org/0009-0002-7702-2980
Arie van der LeeInstitut Européen des Membranes, IEM, CNRS - UMR 5635, Université de Montpellier, ENSCM, Montpellier, France.ORCID https://orcid.org/0000-0002-4567-1831
Frédéric CoutrotSupramolecular Machines and Architectures Team, Institut des Biomolécules Max Mousseron, CNRS, Université de Montpellier, ENSCM, Montpellier, France.ORCID https://orcid.org/0000-0003-1922-9115

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report on the metal-free active template synthesis of [2]rotaxanes through nucleophilic aromatic substitution between an amine and halogenopyridinium derivatives in the presence of a crown ether as the reaction promoter. The influence of the leaving group and counter-ion of the pyridinium moiety was studied. Optimal conditions gave conversion of macrocycle to rotaxane up to 90% with rotaxane:axle ratio as great as 96:4. The ability of the 24-crown-8 and dibenzo-24-crown-8-containing [2]rotaxanes to behave as molecular shuttles was also considered. Mesomeric effects in the original 4-aminopyridinium moiety revealed two discrete, though conjugated, sites of interaction for crown ethers, which allowed for small-amplitude shuttling of the macrocycle. Unexpectedly, crown ether macrocycles mainly interacted around the amino site of the 4-aminopyridinium conjugated system, highlighting the more preponderant iminium mesomeric form. Sole deprotonation of the amino group led to a neutral ylide-kind dipolar [2]rotaxane, in which the crown ether freely shuttled along the entire axle. However, deprotonation-then-carbamoylation of the amino group triggered the small-amplitude shuttling of the macrocycle around the sole positively charged pyridinium site of the 4-aminopyridinium moiety.

Indexed as

metal‐free active templatemolecular shuttlespyridiniumrotaxanes

Identifiers

PMID42171405
PMCPMC13360766

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.